Combined Synopsis/SolicitationActiveN0018926QB059
Cap-dependent endonuclease inhibitors (CENis) - NHRC
DEPT OF DEFENSE / DEPT OF THE NAVY / NAVSUP FLT LOG CTR NORFOLKKey dates?
- Posted?
- May 15, 2026
- Response deadline?
- May 25, 2026, 9:00 PM UTC
- Archive date?
- —
- Archive type?
- auto15
Classification?
- Notice type?
- Combined Synopsis/Solicitation
- Base type?
- Combined Synopsis/Solicitation
- Set-aside?
- No Set aside used
- Set-aside code?
- NONE
- PSC?
- AN42
NAICS?
Issuing office?
- Department?
- DEPT OF DEFENSE
- Sub-tier?
- DEPT OF THE NAVY
- Office?
- NAVSUP FLT LOG CTR NORFOLK
- Office code?
- 017.1700.NAVSUP.NAVSUP GLS.NAVSUP FLC NORFOLK.N00189
- Organization type?
- OFFICE
- Office address?
- NORFOLK, VA, 23511-3392, USA
Place of performance?
- Street?
- —
- Street 2?
- —
- City?
- Galveston
- State?
- Texas
- Zip?
- —
- Country?
- UNITED STATES
Contacts?
- Brian Kinkadeprimary
- Jacob Gephartsecondary
Description?
The preclinical development of Cap-dependent endonuclease inhibitors (CENi), a class of small molecules, as broad-spectrum antiviral therapeutics. The scope of this project includes all activities required to select lead CENi candidates, including in vitro and in vivo efficacy studies and characterization and optimization of lead compounds. This includes Research Support expertise regarding the preclinical development of cap-dependent endonuclease inhibitors (CENis) with viruses that require biosafety level 4 (BSL-4) containment to support the Naval Medical Research Command in Fort Detrick, MD. This work will be performed over a 36-month period.
Attachments (3)?
Other notices in this solicitation?
Similar open contracts
Metadata?
- Notice ID?
- 7ca6661dd9ec4edb86296ad3bc28a805
- Full path?
- DEPT OF DEFENSE.DEPT OF THE NAVY.NAVSUP FLT LOG CTR NORFOLK
- Office code?
- 017.1700.NAVSUP.NAVSUP GLS.NAVSUP FLC NORFOLK.N00189
- Ingested?
- May 16, 2026
- Updated?
- Jun 12, 2026